Researchers from Weill Cornell Medical College and elsewhere present findings from a prostate cancer analysis performed with a computational tool called RegNetDriver, designed to uncover cancer driver mutations based on integrated genomic and epigenomic data. For its proof-of-principle analyses, the team used RegNetDriver to analyze structural variant, transcription factor, variant, promoter, enhancer, and other data gleaned from 521 prostate cancer tumors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.